Clinical Trials Sponsored by AAIPharma

Total 79 results

OncoVista, Inc.
AAIPharma

Unknown

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

Refractory TdT-Positive Leukemia

United States
ApoPharma

Completed

Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects

Asymptomatic HIV Infection

South Africa
ApoPharma

Completed

Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy Volunteers

Healthy

Canada
ApoPharma

Completed

A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia

Friedreich's Ataxia

Belgium, France, Italy, Spain
ApoPharma

Completed

A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia

Friedreich's Ataxia

Canada, Australia, Belgium, France, Italy, Spain
ApoPharma

Completed

Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients

Iron Overload

Egypt, Indonesia, Malaysia
ApoPharma

Completed

Efficacy Study in Removing Excess Iron From the Heart

Hemosiderosis | Thalassemia Major

Greece, Italy
ApoPharma

Completed

Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease

Sickle Cell Disease

Canada
ApoPharma

Completed

A Blinded, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single Doses of Intravenous Deferiprone in Healthy Volunteers

Healthy Volunteers

Canada
ApoPharma

Completed

Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects

Prolonged QTc Interval

United States
ApoPharma

Completed

An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers

Hepatic Impairment

United States
ApoPharma

Completed

An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment

Renal Impairment

Canada
ApoPharma

Completed

Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects

HIV Infection

South Africa
ApoPharma

Completed

Active Drug Surveillance Program of Ferriprox Use

Transfusional Iron Overload

Egypt, Cyprus, Oman, Saudi Arabia, Turkey
ApoPharma

Terminated

Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers

Diabetic Foot Ulcer

United States
ApoPharma

Completed

Pilot Study of the Pharmacokinetic Profile of Deferiprone Sustained-Release Formulation in Healthy Volunteers

Healthy

Canada
ApoPharma

Completed

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Plaque Psoriasis

United States, Canada
AlgiPharma AS
AlgiPharma Australia Pty. Ltd.

Unknown

A Phase 2b Randomised, Placebo Controlled Study of OligoG in Patients With Cystic Fibrosis

Cystic Fibrosis

Australia
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-208

Androgenetic Alopecia

Korea, Republic of
Addpharma Inc.

Completed

A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131

Gastroesophagus Reflux Disease

Korea, Republic of
Addpharma Inc.

Completed

A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132

Gastroesophagus Reflux Disease

Korea, Republic of
Addpharma Inc.

Completed

Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102

Hypertension

Korea, Republic of
Addpharma Inc.

Completed

Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072

Hypertension | Hyperlipidemias

Korea, Republic of
AlgiPharma AS

Completed

A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis (OligoG)

Cystic Fibrosis

United Kingdom, Ireland
Addpharma Inc.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B

Essential Hypertension
Addpharma Inc.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of AD-224

Hypertension,Essential
Addpharma Inc.

Recruiting

A Study to Assess the Safety and Pharmacokinetics of AD-104-A

Hyperlipidemias

Korea, Republic of
Addpharma Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of AD-218

Mixed Dyslipidemia

Korea, Republic of
Addpharma Inc.

Completed

A Study to Compare PK, PD and Safety of the AD-214 and AD-2141

Gastroesophageal Reflux Disease

Korea, Republic of
Addpharma Inc.

Completed

A Study to Compare Pharmacokinetic Parameters and Safety Profiles Between AD-109 and AD-1091

Embolism and Thrombosis

Korea, Republic of
Addpharma Inc.

Completed

A Study to Compare PK, PD and Safety of the AD-214 10/600mg and Rabeprazole

Gastroesophageal Reflux Disease

Korea, Republic of
Addpharma Inc.

Completed

Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension

Hypertension,Essential

Korea, Republic of
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-203

Acute Gastritis | Chronic Gastritis

Korea, Republic of
Addpharma Inc.

Completed

Evaluating the Pharmacokinetic Interactions and Safety Between AD-2111 and AD-2112

Pain

Korea, Republic of
Addpharma Inc.

Completed

Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012

Hypertension | Hyperlipidemias

Korea, Republic of
AlgiPharma AS

Completed

A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection (SMR-2591)

Cystic Fibrosis | Burkholderia Infection

Germany
Addpharma Inc.

Recruiting

Phase III Study to Evaluate the Efficacy and Safety of AD-209

Hypertension,Essential

Korea, Republic of
Addpharma Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of AD-223

Hypertension,Essential

Korea, Republic of
Addpharma Inc.

Recruiting

A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121

Gastro Esophageal Reflux

Korea, Republic of
Addpharma Inc.

Completed

Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022

Hypertension, Essential | Primary Hypercholesterolemia

Korea, Republic of
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-209

Hypertension, Essential

Korea, Republic of
Addpharma Inc.

Completed

A Study to Evaluate the Safety and Pharmacokinetics of AD-221 Compared to Coadministration of AD-221A and AD-221B

Hyperlipidemias

Korea, Republic of
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A

Primary Hypercholesterolemia

Korea, Republic of
Addpharma Inc.

Completed

A Study to Compare PK, PD and Safety of the AD-214-02 and Rabeprazole

Gastroesophageal Reflux Disease

Korea, Republic of
Addpharma Inc.

Completed

Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine

Hypertension | Hypercholesterolemia

Korea, Republic of
Addpharma Inc.

Completed

Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan

Hypertension | Hypercholesterolemia

Korea, Republic of
Addpharma Inc.

Completed

A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole

Gastritis

Korea, Republic of
Addpharma Inc.

Completed

To Evaluate the Pharmacokinetics and Safety of AD-208

Androgenetic Alopecia

Korea, Republic of
Addpharma Inc.

Completed

Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy Volunteers

Osteoporosis

Korea, Republic of
Addpharma Inc.

Completed

Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy Volunteers

Osteoporosis

Korea, Republic of

3

Subscribe